Adherium in US Covid-19 telemedicine tie-up

Medical device and digital healthcare group Adherium has teamed up with US telemedicine provider HGE Health to offer its digital solutions to treat respiratory patients. Pennsylvania-based HGE will evaluate and integrate Adherium’s Hailie technology to remotely monitor patient usage of inhaled respiratory drugs used to treat conditions such as asthma and potentially covid-19. The company’s…

Adherium gets US sales approval

Australasian smart asthma inhaler device maker Adherium (ASX: ADR) has received US Food and Drug Administration clearance for over the counter sales of its Hailie sensors. The company, founded in New Zealand, listed in Australia and headquartered in the United States, manufactures connected respiratory devices. Its’ Hailie sensor attaches to a patient’s asthma inhaler, monitoring…

Manufacturing news briefs — stories you might have missed

EMVision cashed up from three government and non-government grants Medical imaging company EMVision Medical Devices expects to receive $8.8 million in funding from three grant programmes in the current quarter. The company received in November $1.2 million in milestone payments from the Australian Stroke Alliance which is funding its development of a system utilising microwaves…